SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ciphergen Biosystems(CIPH):
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (42)3/18/2002 6:19:38 PM
From: Biomaven  Read Replies (1) of 510
 
tuck,

Thanks. I still don't know the exact relationship between Lumisys, CTI and MAS - I'm guessing they can be considered a single entity controlled by the original inventor.

So if we restrict ourselves to drug discovery products, then it appears that Ciphergen can make, use and exclusively sell them, while CTI (and hence Lumisys) can only make or use them.

If that's right, it's likely all going to turn on whether information is a "drug discovery product." Personally, I would say it is.

I did take a brief look at the abstracts - as you say, much more than ovarian cancer.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News